CASP3 and breast cancer: To examine doxorubicin-induced apoptosis, we measured the caspases 3/7 activities after 24-hour treatment with a range of concentrations (0.3, 0.7, 1.0, and 3.0 μM) of doxorubicin around the reported IC50 for breast cancer cells of 1.0 μM44.